Myocardial infarction increases ACE2 expression in rat and humans von Burrell, Louise M., Risvanis, John, Kubota, Eiji, Dean, Rachael G., MacDonald, Peter S., Lu, Sai, Tikellis, Christos, Grant, Sharon L., Lew, Rebecca A., Smith, A. Ian, Cooper, Mark E., Johnston, Colin I.

Volltext

Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy von Tikellis, Christos, Johnston, Colin I, Forbes, Josephine M, Burns, Wendy C, Burrell, Louise M, Risvanis, John, Cooper, Mark E

Volltext

Blood Pressure-Lowering Effect of an Orally Active Vasopressin V1 Receptor Antagonist in Mineralocorticoid Hypertension in the Rat von Burrell, Louise M, Phillips, Paddy A, Stephenson, J M, Risvanis, J, Rolls, K A, Johnston, C I

Volltext

Effects of drinking on thirst and vasopressin in dehydrated elderly men von Phillips, P. A, Bretherton, M, Risvanis, J, Casley, D, Johnston, C, Gray, L

Volltext

New Hormonal Blockade Strategies in Cardiovascular Disease von I. Johnston, M. Naitoh, J. Risvanis, N. Farina, L. M. Burrell, C.

Volltext

Vasopressin V1 and V2 receptors in diabetes mellitus von Trinder, D, Phillips, P. A, Stephenson, J. M, Risvanis, J, Aminian, A, Adam, W, Cooper, M, Johnston, C. I

Volltext

Vasopressin Receptor Expression in the Placenta von Koukoulas, Irene, Risvanis, John, Douglas-Denton, Rebecca, Burrell, Louise M, Moritz, Karen M, Marelyn Wintour, E

Volltext

Chronic Vasopressin Antagonism in Two-Kidney, One-Clip Renovascular Hypertension von Burrell, L M., Risvanis, J, Phillips, Pa, Naitoh, M, Johnston, Ci

Volltext

Vasopressin receptor antagonism — a therapeutic option in heart failure and hypertension von Burrell, Louise M., Risvanis, John, Johnston, Colin I., Naitoh, Mareo, Balding, Leanne C.

Volltext

In vivo and in vitro characterisation of a nonpeptide vasopressin V 1A and V 2 receptor antagonist (YM087) in the rat von Risvanis, John, Naitoh, Mareo, Johnston, Colin I, Burrell, Louise M

Volltext

[3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand von Trinder, D, Stephenson, J M, Gao, X, Phillips, P A, Risvanis, J, Johnston, C I

Volltext

[3H]desGly-NH29-d(CH2)5[D-Ileu2,Ileu4]AVP : an AVP V2 receptor antagonist radioligand von TRINDER, D, STEPHENSON, J. M, GAO, X, PHILLIPS, P. A, RISVANIS, J, JOHNSTON, C. I

Volltext

Vasopressin and a Nonpeptide Antidiuretic Hormone Receptor Antagonist (OPC-31260) von Burrell, Louise M., Phillips, Paddy A., Stephenson, J. M., Risvanis, J., Johnston, Colin I.

Volltext

Preclinical Pharmacology of Angiotensin II Receptor Antagonists: Update and Outstanding Issues von Johnston, Colin I, Risvanis, John

Volltext

Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat von Burrell, Louise M, Phillips, Paddy A, Risvanis, John, Chan, Robert K, Aldred, Kathryn L, Johnston, Colin I

Volltext

Long-term effects of nonpeptide vasopressin V 2 antagonist OPC-31260 in heart failure in the rat von Burrell, Louise M, Phillips, Paddy A, Risvanis, John, Chan, Robert K, Aldred, Kathryn L, Johnston, Colin I

Volltext

EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V1 RECEPTOR ANTAGONIST von Burrell, L. M., Phillips, P. A., Stephenson, J., Risvanis, J., Hutchins, A-M., Johnston, C. I.

Volltext

Preclinical pharmacology of angiotensin II receptor antagonists: Update and outstanding issues: New pharmacologic approaches to the management of hypertension von JOHNSTON, C. I, RISVANIS, J

Volltext

EFFECTS OF ANTI-EMETICS ON WATER EXCRETION IN HUMANS von Phillips, P. A., Burrell, L. M., Risvanis, J., Stephenson, J., Johnston, C. I., Hutchins, A-M.

Volltext

In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat von Risvanis, J, Naitoh, M, Johnston, C I, Burrell, L M

Volltext